Pulmonary mucosal dendritic cells in T-cell activation: Implications for TB therapy

Expert Review of Respiratory Medicine

Volumn 5, Issue 1, 2011, Pages 75-85

  McCormick, Sarah ^a,b   Shaler, Christopher R ^a,b   Xing, Zhou ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

alveolar macrophages; DC vaccines; dendritic cells; ex vivo manipulated DC; lung; migration; Mycobacterium tuberculosis; T cells; tuberculosis

Indexed keywords

DENDRITIC CELL VACCINE; KILLER CELL ACTIVATING RECEPTOR ASSOCIATED PROTEIN;

ANTIGEN PRESENTING CELL; BCG VACCINATION; CELL HETEROGENEITY; CELL MEMBRANE RESISTANCE; CELLULAR IMMUNITY; CROSS PRESENTATION; DENDRITIC CELL; DISEASE PREDISPOSITION; EX VIVO STUDY; HUMAN; IN VITRO STUDY; LUNG TUBERCULOSIS; LYMPHOCYTE HOMING; MYCOBACTERIOSIS; NONHUMAN; RESPIRATORY TRACT MUCOSA; REVIEW; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

EID: 79952156815     PISSN: 17476348     EISSN: 17476356     Source Type: Journal    
DOI: 10.1586/ers.10.81     Document Type: Review

References (81)

1. Naik SH, Metcalf D, van Nieuwenhuijze A et al. Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes. Nat. Immunol. 7(6), 663-671 (2006). (Pubitemid 43797348)
2. Liu K, Waskow C, Liu X et al. Origin of dendritic cells in peripheral lymphoid organs of mice. Nat. Immunol. 8(6), 578-583 (2007). (Pubitemid 46785121)
3. Sung SS, Fu SM, Rose CE Jr et al. A major lung CD103 (aE)-b7 integrin-positive epithelial dendritic cell population expressing Langerin and tight junction proteins. J. Immunol. 176(4), 2161-2172 (2006). (Pubitemid 43201663)
4. Jakubzick C, Tacke F, Ginhoux F et al. Blood monocyte subsets differentially give rise to CD103+ and CD103- pulmonary dendritic cell populations. J. Immunol. 180(5), 3019-3027 (2008).
5. Maus UA, Koay MA, Delbeck T et al. Role of resident alveolar macrophages in leukocyte traffic into the alveolar air space of intact mice. Am. J. Physiol. Lung Cell Mol. Physiol. 282(6), L1245-L1252 (2002). (Pubitemid 34654580)
6. Vermaelen K, Pauwels R. Accurate and simple discrimination of mouse pulmonary dendritic cell and macrophage populations by flow cytometry: methodology and new insights. Cytometry Part A 61A(2), 170-177 (2004). (Pubitemid 39362291)
7. Kugathasan K, Roediger E, Small C-L et al. CD11c+ antigen presenting cells from the alveolar space, lung parenchyma and spleen differ in their phenotype and capabilities to activate naive and antigen-primed T cells. BMC Immunol. 9(1), 48 (2008).
8. Cleret A, Quesnel-Hellmann A, Vallon- Eberhard A et al. Lung dendritic cells rapidly mediate anthrax spore entry through the pulmonary route. J. Immunol. 178(12), 7994-8001 (2007). (Pubitemid 46898070)
9. Jakubzick C, Tacke F, Llodra J, van Rooijen N, Randolph GJ. Modulation of dendritic cell trafficking to and from the airways. J. Immunol. 176(6), 3578-3584 (2006). (Pubitemid 43364005)
10. Wolf AJ, Linas B, Trevejo-Nunez GJ et al. Mycobacterium TB infects dendritic cells with high frequency and impairs their function in vivo. J. Immunol. 179(4), 2509-2519 (2007).
11. Gonzalez-Juarrero M, Shim TS, Kipnis A, Junqueira-Kipnis AP, Orme IM. Dynamics of macrophage cell populations during murine pulmonary TB. J. Immunol. 171(6), 3128-3135 (2003). (Pubitemid 37093536)
12. Kirby AC, Coles MC, Kaye PM. Alveolar macrophages transport pathogens to lung draining lymph nodes. J. Immunol. 183(3), 1983-1989 (2009).
13. Sertl K, Takemura T, Tschachler E et al. Dendritic cells with antigen-presenting capability reside in airway epithelium, lung parenchyma, and visceral pleura. J. Exp. Med. 163(2), 436-451 (1986). (Pubitemid 16113078)
14. Schon-Hegrad MA, Oliver J, McMenamin PG, Holt PG. Studies on the density, distribution, and surface phenotype of intraepithelial class II major histocompatibility complex antigen (Ia)-bearing dendritic cells (DC) in the conducting airways. J. Exp. Med. 173(6), 1345-1356 (1991).
15. Jahnsen FL, Strickland DH, Thomas JA et al. Accelerated antigen sampling and transport by airway mucosal dendritic cells following inhalation of a bacterial stimulus. J. Immunol. 177(9), 5861-5867 (2006). (Pubitemid 44628799)
16. del Rio M-L, Rodriguez-Barbosa J-I, Kremmer E, Forster R. CD103- and CD103+ bronchial lymph node dendritic cells are specialized in presenting and cross-presenting innocuous antigen to CD4+ and CD8+ T cells. J. Immunol. 178(11), 6861-6866 (2007). (Pubitemid 46847411)
17. GeurtsvanKessel CH, Willart MA, van Rijt LS et al. Clearance of influenza virus from the lung depends on migratory langerin+CD11b- but not plasmacytoid dendritic cells. J. Exp. Med. 205(7), 1621-1634 (2008). (Pubitemid 351962026)
18. Anis MM, Fulton SA, Reba SM et al. Modulation of pulmonary dendritic-cell function during mycobacterial infection. Infect. Immun. 76(2), 671-677 (2007).
19. Raymond M, Rubio M, Fortin G et al. Selective control of SIRP-a-positive airway dendritic cell trafficking through CD47 is critical for the development of T(H)2- mediated allergic inflammation. J. Allergy Clin. Immunol. 124(6), 1333-1342 (2009).
20. Skld M, Behar SM. TB triggers a tissue-dependent program of differentiation and acquisition of effector functions by circulating monocytes. J. Immunol. 181(9), 6349-6360 (2008).
21. Fahlen-Yrlid L, Gustafsson T, Westlund J et al. CD11chigh dendritic cells are essential for activation of CD4+ T cells and generation of specific antibodies following mucosal immunization. J. Immunol. 183(8), 5032-5041 (2009).
22. van Rijt LS, Jung S, KleinJan A et al. In vivo depletion of lung CD11c+ dendritic cells during allergen challenge abrogates the characteristic features of asthma. J. Exp. Med. 201(6), 981-991 (2005). (Pubitemid 40524467)
23. von Garnier C, Filgueira L, Wikstrom M et al. Anatomical location determines the distribution and function of dendritic cells and other APCs in the respiratory tract. J. Immunol. 175(3), 1609-1618 (2005). (Pubitemid 41023063)
24. Varol C, Landsman L, Fogg DK et al. Monocytes give rise to mucosal, but not splenic, conventional dendritic cells. J. Exp. Med. 204(1), 171-180 (2007). (Pubitemid 46148767)
25. Landsman L, Varol C, Jung S. Distinct differentiation potential of blood monocyte subsets in the lung. J. Immunol. 178(4), 2000-2007 (2007). (Pubitemid 46233396)
26. Landsman L, Jung S. Lung macrophages serve as obligatory intermediate between blood monocytes and alveolar macrophages. J. Immunol. 179(6), 3488-3494 (2007).
27. de Heer HJ, Hammad H, Soullie T et al. Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J. Exp. Med. 200(1), 89-98 (2004). (Pubitemid 38924731)
28. Masten BJ, Olson GK, Tarleton CA et al. Characterization of myeloid and plasmacytoid dendritic cells in human lung. J. Immunol. 177(11), 7784-7793 (2006). (Pubitemid 44846294)
29. Wang H, Peters N, Schwarze J. Plasmacytoid dendritic cells limit viral replication, pulmonary inflammation, and airway hyperresponsiveness in respiratory syncytial virus infection. J. Immunol. 177(9), 6263-6270 (2006). (Pubitemid 44628844)
30. Reljic R, Sano CD, Crawford C et al. Time course of mycobacterial infection of dendritic cells in the lungs of intranasally infected mice. Tuberculosis (Edinburgh, Scotland) 85(1), 81-88 (2005). (Pubitemid 40431319)
31. Ernst JD. Macrophage receptors for Mycobacterium TB. Infect. Immun. 66(4), 1277-1281 (1998).
32. Tailleux L, Schwartz O, Herrmann J-L et al. DC-SIGN is the major Mycobacterium TB receptor on human dendritic cells. J. Exp. Med. 197(1), 121-127 (2003). (Pubitemid 36110263)
33. Tailleux L, Pham-Thi N, Bergeron- Lafaurie A et al. DC-SIGN induction in alveolar macrophages defines privileged target host cells for mycobacteria in patients with TB. PLoS Med. 2(12), e381 (2005).
34. Balboa L, Romero MM, Yokobori N et al. Mycobacterium TB impairs dendritic cell response by altering CD1b, DC-SIGN and MR profile. Immunol. Cell Biol. 88, 716-726 (2010).
35. Gupta D, Sharma S, Singhal J et al. Suppression of TLR2-induced IL-12, reactive oxygen species, and inducible nitric oxide synthase expression by Mycobacterium TB antigens expressed inside macrophages during the course of infection. J. Immunol. 184(10), 5444-5455 (2010).
36. Bodnar KA, Serbina NV, Flynn JL. Fate of Mycobacterium TB within murine dendritic cells. Infect. Immun. 69(2), 800-809 (2001). (Pubitemid 32109542)
37. Ordway D, Henao-Tamayo M, Orme IM, Gonzalez-Juarrero M. Foamy macrophages within lung granulomas of mice infected with Mycobacterium TB express molecules characteristic of dendritic cells and antiapoptotic markers of the TNF receptor-associated factor family. J. Immunol. 175(6), 3873-3881 (2005). (Pubitemid 41292047)
38. Russell DG, Cardona PJ, Kim MJ, Allain S, Altare F. Foamy macrophages and the progression of the human TB granuloma. Nat. Immunol. 10(9), 943-948 (2009).
39. Bafica A, Scanga CA, Feng CG et al. TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium TB. J. Exp. Med. 202(12), 1715-1724 (2005). (Pubitemid 41815877)
40. Vesosky B, Rottinghaus EK, Stromberg P, Turner J, Beamer G. CCL5 participates in early protection against Mycobacterium TB. J. Leukoc. Biol. 87(6), 1153-1165 (2010).
41. Peters W, Cyster JG, Mack M et al. CCR2-dependent trafficking of F4/80dim macrophages and CD11cdim/intermediate dendritic cells is crucial for T cell recruitment to lungs infected with Mycobacterium TB. J. Immunol. 172(12), 7647-7653 (2004). (Pubitemid 38747630)
42. Wolf AJ, Desvignes L, Linas B et al. Initiation of the adaptive immune response to Mycobacterium TB depends on antigen production in the local lymph node, not the lungs. J. Exp. Med. 205(1), 105-115 (2008). (Pubitemid 351185719)
43. Tian T, Woodworth J, Sköld M, Behar SM. In vivo depletion of CD11c+ cells delays the CD4+ T cell response to Mycobacterium TB and exacerbates the outcome of infection. J. Immunol. 175(5), 3268-3272 (2005). (Pubitemid 41170548)
44. Jung S, Unutmaz D, Wong P et al. In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. Immunity 17(2), 211-220 (2002). (Pubitemid 35245963)
45. Kashino SS, Vallerskog T, Martens G et al. Initiation of acquired immunity in the lungs of mice lacking lymph nodes after infection with aerosolized Mycobacterium TB. Am. J. Pathol. 176(1), 198-204 (2010).
46. Day TA, Koch M, Nouailles G et al. Secondary lymphoid organs are dispensable for the development of T-cell-mediated immunity during TB. Eur. J. Immunol. 40(6), 1663-1673 (2010).
47. Sallusto F, Schaerli P, Loetscher P et al. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur. J. Immunol. 28(9), 2760-2769 (1998). (Pubitemid 28425234)
48. Dieu M-C, Vanbervliet B, Vicari A et al. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J. Exp. Med. 188(2), 373-386 (1998). (Pubitemid 28357765)
49. Sanchez-Sanchez N, Riol-Blanco L, Rodriguez-Fernandez JL. The multiple personalities of the chemokine receptor CCR7 in dendritic cells. J. Immunol. 176(9), 5153-5159 (2006).
50. Olmos S, Stukes S, Ernst JD. Ectopic activation of Mycobacterium TB-specific CD4+ T cells in lungs of CCR7-/- mice. J. Immunol. 184(2), 895-901 (2010).
51. McCormick S, Santosuosso M, Small CL et al. Mucosally delivered dendritic cells activate T cells independently of IL-12 and endogenous APCs. J. Immunol. 181(4), 2356-2367 (2008).
52. Khader SA, Partida-Sanchez S, Bell G et al. Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium TB infection. J. Exp. Med. 203(7), 1805-1815 (2006). (Pubitemid 44036285)
53. Gao X, Wang S, Fan Y et al. CD8+DC, but not CD8-DC, isolated from BCG-infected mice reduces pathological reactions induced by mycobacterial challenge infection. PLoS One 5(2), e9281 (2010).
54. Edelson BT, KC W, Juang R et al. Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8a+ conventional dendritic cells. J. Exp. Med. 207(4), 823-836 (2010).
55. Reiley WW, Calayag MD, Wittmer ST et al. ESAT-6-specific CD4 T cell responses to aerosol Mycobacterium TB infection are initiated in the mediastinal lymph nodes. Proc. Natl Acad. Sci. USA 105(31), 10961-10966 (2008).
56. Shaler CR, Kugathasan K. McCormick S et al. Pulmonary mycobacterial granuloma: increased IL-10 production contributes to establishing a symbiotic host-microbe microenviroment. Am. J. Path. (2010) (In Press).
57. Divangahi M, Chen M, Gan H et al. Mycobacterium TB evades macrophage defenses by inhibiting plasma membrane repair. Nat. Immunol. 10(8), 899-906 (2009).
58. Divangahi M, Desjardins D, Nunes-Alves C, Remold HG, Behar SM. Eicosanoid pathways regulate adaptive immunity to Mycobacterium TB. Nat. Immunol. 11(8), 751-758 (2010).
59. Wakeham J, Wang J, Xing Z. Genetically determined disparate innate and adaptive cell-mediated immune responses to pulmonary Mycobacterium bovis BCG infection in C57BL/6 and BALB/c mice. Infect. Immun. 68(12), 6946-6953 (2000). (Pubitemid 32463407)
60. Martins de Sousa E, Bonfim de Bortoli F, Amaral EP et al. Acute immune response to Mycobacterium massiliense in C57BL/6 and BALB/c mice. Infect. Immun. 78(4), 1571-1581 (2010).
61. Chackerian AA, Alt JM, Perera TV, Dascher CC, Behar SM. Dissemination of Mycobacterium TB is influenced by host factors and precedes the initiation of T-cell immunity. Infect. Immun. 70(8), 4501-4509 (2002). (Pubitemid 34790962)
62. Cardona P-J, Gordillo S, Diaz J et al. Widespread bronchogenic dissemination makes DBA/2 mice more susceptible than C57BL/6 mice to experimental aerosol infection with Mycobacterium TB. Infect. Immun. 71(10), 5845-5854 (2003). (Pubitemid 37205638)
63. Divangahi M, Yang T, Kugathasan K et al. Critical negative regulation of Type 1 T cell immunity and immunopathology by signaling adaptor DAP12 during intracellular infection. J. Immunol. 179(6), 4015-4026 (2007).
64. Chu CL, Yu YL, Shen KY et al. Increased TLR responses in dendritic cells lacking the ITAM-containing adapters DAP12 and FcRγ. Eur. J. Immunol. 38(1), 166-173 (2008).
65. Bouchon A, Hernandez-Munain C, Cella M, Colonna M. A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells. J. Exp. Med. 194(8), 1111-1122 (2001). (Pubitemid 32995781)
66. Lanier LL. DAP10- and DAP12-associated receptors in innate immunity. Immunol. Rev. 227(1), 150-160 (2009).
67. Ronan EO, Lee LN, Beverley PCL, Tchilian EZ. Immunization of mice with a recombinant adenovirus vaccine inhibits the early growth of Mycobacterium TB after infection. PLoS One 4(12), e8235 (2009).
68. Rodrigues LC, Pereira SM, Cunha SS et al. Effect of BCG revaccination on incidence of TB in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial. Lancet 366(9493), 1290-1295 (2005). (Pubitemid 41416584)
69. Group KPT. Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and TB in Malawai. Lancet 366, 1290-1295 (1996).
70. Cardona PJ, Amat I, Gordillo S et al. Immunotherapy with fragmented Mycobacterium TB cells increases the effectiveness of chemotherapy against a chronical infection in a murine model of TB. Vaccine 23(11), 1393-1398 (2005). (Pubitemid 40127332)
71. Birkholz K, Schwenkert M, Kellner C et al. Targeting of DEC-205 on human dendritic cells results in efficient MHC class II-restricted antigen presentation. Blood 116(13), 2277-2285 (2010).
72. Bonifaz LC, Bonnyay DP, Charalambous A et al. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J. Exp. Med. 199(6), 815-824 (2004). (Pubitemid 38375201)
73. Bivas-Benita M, van Meijgaarden KE, Franken KL et al. Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A*0201-restricted T-cell epitopes of Mycobacterium TB. Vaccine 22(13-14), 1609-1615 (2004). (Pubitemid 38447207)
74. Rosada RS, de la Torre LG, Frantz FG et al. Protection against TB by a single intranasal administration of DNA-hsp65 vaccine complexed with cationic liposomes. BMC Immunol. 9, 38 (2008).
75. Roediger EK, Kugathasan K, Zhang X, Lichty BD, Xing Z. Heterologous boosting of recombinant adenoviral prime immunization with a novel vesicular stomatitis virus-vectored TB vaccine. Mol. Ther. 16(6), 1161-1169 (2008). (Pubitemid 351737083)
76. Malowany JI, McCormick S, Santosuosso M et al. Development of cell-based TB vaccines: genetically modified dendritic cell vaccine is a much more potent activator of CD4 and CD8 T cells than peptide- or protein-loaded counterparts. Mol. Ther. 13(4), 766-775 (2006).
77. Dietz AB, Bulur PA, Brown CA, Pankratz VS, Vuk-Pavlovic S. Maturation of dendritic cells infected by recombinant adenovirus can be delayed without impact on transgene expression. Gene Ther. 8(5), 419-423 (2001). (Pubitemid 32241942)
78. Antonelli LRV, Gigliotti Rothfuchs A, Gonalves R et al. Intranasal poly-IC treatment exacerbates TB in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population. J. Clin. Invest. 120(5), 1674-1682 (2010).
79. Santosuosso M, Zhang X, McCormick S et al. Mechanisms of mucosal and parenteral TB vaccinations: adenoviral-based mucosal immunization preferentially elicits sustained accumulation of immune protective CD4 and CD8 T cells within the airway lumen. J. Immunol. 174(12), 7986-7994 (2005). (Pubitemid 40806309)
80. DeFrancesco L. Landmark approval for Dendreons cancer vaccine. Nat. Biotech. 28(6), 531-532 (2010).
81. Kim TW, Hung CF, Boyd D et al. Enhancing DNA vaccine potency by combining a strategy to prolong dendritic cell life with intracellular targeting strategies. J. Immunol. 171(6), 2970-2976 (2003). (Pubitemid 37093519)